NDA[removed]S-005 FDA Approved Labeling Text dated[removed]

First Page		Document Content
Date: 2009-03-02 13:28:43 Health Psychiatry Acetamides Xyrem Gamma-Hydroxybutyric acid Narcolepsy Excessive daytime sleepiness Cataplexy Modafinil Sleep disorders Medicine Sleep		NDA[removed]S-005 FDA Approved Labeling Text dated[removed] Add to Reading List Source URL: www.biopsychiatry.com Download Document from Source Website File Size: 300,83 KB Share Document on Facebook

	SLEEP APNEA EVALUATION SPECIFICATIONS Even mild cases of sleep apnea require FAA clearance. This guidance should help aircrew and controllers that need to document that their condition does not present a problem with day DocID: 1r4BY - View Document
	BB Frontline Employeepub DocID: 1qwoc - View Document
	RESEARCH ARTICLE Efficacy of Modafinil on Excessive Daytime Sleepiness in Prader–Willi Syndrome V. Cochen De Cock,1 G. Diene,2 C. Molinas,2 V. Dauriac-Le Masson,3 I. Kieffer,2 E. Mimoun,2 M. Tiberge,4 and M. Tauber2* DocID: 1d91l - View Document
	Closeup of a pretty young woman sleeping in bed DocID: 19wVt - View Document
	Modafinil Improves Alertness, Vigilance, and Executive Function During Simulated Night Shifts James K. Walsh, PhD1,2; Angela C. Randazzo, PhD1; Kara L. Stone, MA1; Paula K. Schweitzer, PhD1 1Sleep Medicine and Research DocID: 18t6j - View Document